Literature DB >> 1827141

Macrophage stimulating protein: purification, partial amino acid sequence, and cellular activity.

A Skeel1, T Yoshimura, S D Showalter, S Tanaka, E Appella, E J Leonard.   

Abstract

Macrophage stimulating protein (MSP) was purified to homogeneity from human blood plasma by selection of biologically active fractions obtained by sequential immunoaffinity and high pressure liquid ion exchange chromatography. By sodium dodecyl sulfate-polyacrylamide gel electrophoresis the molecular mass of MSP was 70 kilodaltons (kD); under reducing conditions two gel bands were seen, at 47 and 22 kD. The disulfide-linked two-chain structure of MSP was confirmed by separation of reduced and alkylated MSP chains. A computer search comparison of six partial sequences of MSP digests showed that MSP has not been recorded in data banks of protein sequences. Two MSP fragments had greater than 80% identity in overlaps of 12-16 residues to sequences in the protein family that includes human prothrombin, plasminogen, and hepatocyte growth factor. The concentration of purified MSP required for half-maximal biological activity was the order of 10(-10) M. In addition to making mouse resident peritoneal macrophages responses to chemoattractants, MSP caused the appearance of long cytoplasmic processes and pinocytic vesicles in freshly plated macrophages. MSP also caused phagocytosis via the C3b receptor, CR1. Whereas resident peritoneal macrophages bind but do not ingest sheep erythrocytes opsonized with IgM anti-Forssman antibody and mouse C3b, addition of MSP caused ingestion. Thus, MSP causes direct or indirect activation of two receptors of the mouse resident peritoneal macrophage, CR1 and the C5a receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827141      PMCID: PMC2118857          DOI: 10.1084/jem.173.5.1227

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Three-dimensional structure of the kringle sequence: structure of prothrombin fragment 1.

Authors:  C H Park; A Tulinsky
Journal:  Biochemistry       Date:  1986-07-15       Impact factor: 3.162

2.  Disposable microliter immunoabsorbent columns: construction and operation.

Authors:  E J Leonard; A Skeel
Journal:  J Immunol Methods       Date:  1985-10-10       Impact factor: 2.303

3.  Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.

Authors:  S D Showalter; M Zweig; B Hampar
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

4.  Molecular cloning and expression of human hepatocyte growth factor.

Authors:  T Nakamura; T Nishizawa; M Hagiya; T Seki; M Shimonishi; A Sugimura; K Tashiro; S Shimizu
Journal:  Nature       Date:  1989-11-23       Impact factor: 49.962

5.  Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme.

Authors:  J G Bender; L C McPhail; D E Van Epps
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

6.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.

Authors:  C Bianco; F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

7.  In vivo activation of macrophage C3 receptors for phagocytosis.

Authors:  F M Griffin; P J Mullinax
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

8.  Communication between receptors for different ligands on a single cell: ligation of fibronectin receptors induces a reversible alteration in the function of complement receptors on cultured human monocytes.

Authors:  S D Wright; M R Licht; L S Craigmyle; S C Silverstein
Journal:  J Cell Biol       Date:  1984-07       Impact factor: 10.539

9.  Connective tissue proteins and phagocytic cell function. Laminin enhances complement and Fc-mediated phagocytosis by cultured human macrophages.

Authors:  J F Bohnsack; H K Kleinman; T Takahashi; J J O'Shea; E J Brown
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

10.  Tissue-specific phosphorylation of complement receptors CR1 and CR2.

Authors:  P S Changelian; D T Fearon
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more
  39 in total

Review 1.  Invasive growth: from development to metastasis.

Authors:  Paolo M Comoglio; Livio Trusolino
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  Role of STK in mouse liver macrophage and endothelial cell responsiveness during acute endotoxemia.

Authors:  Debra L Laskin; Li Chen; Pamela A Hankey; Jeffrey D Laskin
Journal:  J Leukoc Biol       Date:  2010-05-07       Impact factor: 4.962

3.  Macrophage stimulating protein is a novel neurotrophic factor.

Authors:  M C Stella; A Vercelli; M Repici; A Follenzi; P M Comoglio
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

4.  Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells.

Authors:  Mahdia Benkhoucha; Marie-Laure Santiago-Raber; Gregory Schneiter; Michel Chofflon; Hiroshi Funakoshi; Toshikazu Nakamura; Patrice H Lalive
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-23       Impact factor: 11.205

5.  Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility.

Authors:  O Sakamoto; A Iwama; R Amitani; T Takehara; N Yamaguchi; T Yamamoto; K Masuyama; T Yamanaka; M Ando; T Suda
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

6.  Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals.

Authors:  Takashi Kato
Journal:  Biomed Rep       Date:  2017-10-18

7.  Differential screening of a human chromosome 3 library identifies hepatocyte growth factor-like/macrophage-stimulating protein and its receptor in injured lung. Possible implications for neuroendocrine cell survival.

Authors:  C G Willett; D I Smith; V Shridhar; M H Wang; R L Emanuel; K Patidar; S A Graham; F Zhang; V Hatch; D J Sugarbaker; M E Sunday
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 8.  Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-08       Impact factor: 4.553

9.  Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice.

Authors:  J A Bezerra; T L Carrick; J L Degen; D Witte; S J Degen
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

10.  Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines.

Authors:  Rebecca J McClaine; Aaron M Marshall; Purnima K Wagh; Susan E Waltz
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.